You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fluorocholine

Showing 1 - 25 of 55
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fluorocholine PET/CT Trial (18F-fluorocholine PET/CT.)

Not yet recruiting
  • Fluorocholine PET/CT
  • 18F-fluorocholine PET/CT.
  • (no location specified)
Oct 24, 2022

Parathyroid Adenoma Trial (18Fluorocholine)

Not yet recruiting
  • Parathyroid Adenoma
  • (no location specified)
May 26, 2023

18F-fluorocholine, Positron-Emission Tomography, Hyperparathyroidism, Primary Trial in Toronto ([F-18]-FCH PET/MRI)

Active, not recruiting
  • 18F-fluorocholine
  • +2 more
  • [F-18]-FCH PET/MRI
  • Toronto, Ont, Canada
    UHN
Dec 9, 2022

Brain Metastases Trial in New York (18F-FCH PET Scan)

Completed
  • Brain Metastases
  • 18F-FCH PET Scan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 15, 2022

Prostate Cancer Trial in Tripler AMC (Fluourine-18 Fluoromethylcholine PET/CT Imaging)

Completed
  • Prostate Cancer
  • Fluourine-18 Fluoromethylcholine PET/CT Imaging
  • Tripler AMC, Hawaii
    Tripler Army Medical Center
Jul 19, 2022

Hepatocellular Carcinoma Non-resectable Trial in Honolulu (Fluorine-18 fluorocholine)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Fluorine-18 fluorocholine
  • Honolulu, Hawaii
    The Queen's Medical Center
Mar 28, 2022

Prostate Cancer, 18F- Fluorocholine, PSMA PET Trial (Radiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine)

Not yet recruiting
  • Prostate Cancer
  • +5 more
  • Radiopharmaceutical 18F-JK-PSMA-7
  • Radiopharmaceutical 18F-Fluorocholine
  • (no location specified)
Nov 17, 2022

Hyperparathyroidism, Primary Trial in San Francisco (18F-Fluorocholine, Positron Emission Tomography (PET))

Completed
Has Results
  • Hyperparathyroidism, Primary
  • San Francisco, California
    University of California, San Francisco
Sep 21, 2021

Hyperparathyroidism, Primary Trial in San Francisco (18F-Fluorocholine, Positron emission tomography (PET))

Recruiting
  • Hyperparathyroidism, Primary
  • San Francisco, California
    University of California, San Francisco
Aug 17, 2021

Lesion With Known or Suspected F-choline Uptake Trial in Montréal (F-choline intravenous injection)

Recruiting
  • Lesion With Known or Suspected F-choline Uptake
  • F-choline intravenous injection
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'université de Montréal
Dec 6, 2022

F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in

Completed
  • Prostate Cancer
    • Lausanne, CH, Switzerland
      Centre Hospitalier Universitaire Vaudois
    Jul 22, 2021

    Multiple Myeloma Trial in Besançon, Dijon (FDG and FCH PET/CT)

    Recruiting
    • Multiple Myeloma
    • FDG and FCH PET/CT
    • Besançon, France
    • +2 more
    Mar 24, 2022

    Prostate Cancer, Prostate Cancer Recurrent Trial in France (F-18-PSMA-1007, F-18-Fluorocholine)

    Completed
    • Prostate Cancer
    • Prostate Cancer Recurrent
    • Clermont-Ferrand, France
    • +5 more
    Jun 28, 2021

    18F-Fluorocholine PET/CT in Medullary Thyroid Cancer

    Active, not recruiting
    • Medullary Thyroid Cancer
    • 18F-fluorocholine PET/CT
    • Ljubljana, Slovenia
      Department for nuclear medicine, University medical centre Ljubl
    Nov 3, 2020

    Hyperparathyroidism, Parathyroid Adenoma Trial (We assessed sensitivity of 18F-FCH PET/CT in preoperative localisation of

    Completed
    • Hyperparathyroidism
    • Parathyroid Adenoma
    • We assessed sensitivity of 18F-FCH PET/CT in preoperative localisation of hyperfunctioning parathyroid tissue in patients with primary hyperparathyroidism
    • (no location specified)
    Sep 25, 2020

    Patients Eligible to a Curative Treatment for Primary HCC Trial in La Tronche, Lyon, Pierre-Bénite (PET/MRI system (SIEMENS AG,

    Recruiting
    • Patients Eligible to a Curative Treatment for Primary HCC
    • PET/MRI system (SIEMENS AG, Munich, Germany; distributed in France by SIEMENS S.A.S, Saint-Denis, France)
    • La Tronche, France
    • +3 more
    Jan 12, 2021

    Prostate Cancer, Fluorocholine Trial in Hualien (18F-fluorocholine)

    Completed
    • Prostate Cancer
    • Fluorocholine
    • Hualien, Taiwan
      Hualien Tzu Chi Hospital
    Apr 9, 2020

    Hyperparathyroidism Trial in Hualien (18F-fluorocholine PET/CT)

    Completed
    • Hyperparathyroidism
    • 18F-fluorocholine PET/CT
    • Hualien, Taiwan
      Hualien Tzu Chi Hospital
    Mar 18, 2020

    18F-fluorocholine PET-MR Imaging of Coronary Plaque

    Completed
    • Myocardial Infarction
    • +6 more
    • PET-MRI
    • Optical Coherence Tomography
    • Maastricht, Limburg, Netherlands
      Maastricht University Medical Centre
    Feb 19, 2020

    Prostate Cancer Trial in San Francisco (Carbon C 11 Choline, Fluorine F 18 Choline, Positron Emission Tomography (PET) /

    Completed
    Has Results
    • Prostate Cancer
    • Carbon C 11 Choline
    • +2 more
    • San Francisco, California
      University of California San Francisco
    Oct 27, 2020

    Prostate Cancer Trial in Australia, Canada, United Kingdom (18F-FCH PET/MRI Scan)

    Completed
    • Prostate Cancer
    • 18F-FCH PET/MRI Scan
    • Sydney, New South Wales, Australia
    • +9 more
    Apr 4, 2022

    Parathyroid Diseases Trial in Taipei (18F-choline PET)

    Completed
    • Parathyroid Diseases
    • 18F-choline PET
    • Taipei, Taiwan
      National Taiwan Univeristy Hospital
    Jun 25, 2019

    Carcinoma, Hepatocellular Trial in Dijon (FDG Positron Emission Tomography, FCH Positron Emission Tomography)

    Unknown status
    • Carcinoma, Hepatocellular
    • FDG Positron Emission Tomography
    • FCH Positron Emission Tomography
    • Dijon, France
      Emilie REDERSTORFF
    Mar 14, 2019

    Prostate Cancer Recurrent Trial in Saint-Beauzire (DCFPyL)

    Unknown status
    • Prostate Cancer Recurrent
    • DCFPyL
    • Saint-Beauzire, France
      CURIUM PET France
    Feb 1, 2021

    Prostate Cancer Trial in Hamilton, London, Toronto ([F-18]-FCH, PET scan, MRI scan)

    Terminated
    • Prostate Cancer
    • [F-18]-FCH
    • +2 more
    • Hamilton, Ontario, Canada
    • +2 more
    May 3, 2019